[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:IDXX":3,"prompts:company:0000874716":22,"buybacks:0000874716:12":49,"months:0000874716:36":105,"side:events:0000874716":146,"filings:0000874716":169},{"status":4,"company":5,"choices":20,"suggestions":21},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":15,"coverage":16},"0000874716","Idexx Laboratories Inc","IDXX","NASD",[11],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:IDXX","Common Stock",null,false,{"buybacks":17},{"published":18,"published_at":19},true,"2026-11-17",[],[],{"placement":23,"items":24},"company",[25,30,34,38,44],{"id":26,"title":27,"hint":28,"kind":29,"question":27,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":31,"title":32,"hint":33,"kind":29,"question":32,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":35,"title":36,"hint":37,"kind":29,"question":36,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":39,"title":40,"hint":41,"kind":42,"question":14,"target":43},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":45,"title":46,"hint":47,"kind":48,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"company":50,"data_as_of":51,"checked_at":52,"has_active_program":18,"authorized_total":53,"remaining_total":61,"nearest_expiration":64,"programs":66,"recent_quarters":86,"did_asr":15,"asrs":104},{"cik":6,"name":7,"ticker":8,"exchange":9},"2026-09-30","2026-11-18T07:30:21.421006Z",{"value":54,"status":55,"as_of":51,"source":56},53838720000,"estimated",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"0000874716-26-000135","10-Q","2026-11-02","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F874716\u002F000087471626000135\u002F",{"value":62,"status":55,"as_of":51,"source":63},1624804252.8,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":14,"status":65,"as_of":14,"source":14},"not_found",[67],{"authorized":68,"unit":70,"authorized_as_stated":71,"price_as_of":75,"date_authorized":76,"expiration_date":79,"remaining":80,"remaining_as_stated":82,"description":85},{"value":54,"status":55,"as_of":51,"source":69},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"shares",{"value":72,"status":73,"as_of":51,"source":74},78000000,"reported",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"2026-11-18",{"value":77,"status":73,"as_of":51,"source":78},"1999-08-13",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":14,"status":65,"as_of":14,"source":14},{"value":62,"status":55,"as_of":51,"source":81},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":83,"status":73,"as_of":51,"source":84},2353970,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"Board of Directors has approved the repurchase of up to 78 million shares of common stock in the open market or in negotiated transactions pursuant to the Company's share repurchase program. The initial program was approved and announced on August 13, 1999, and the maximum number of shares that may be purchased under the program has been increased by the Board of Directors on numerous occasions.…",[87,94],{"period_start":88,"period_end":89,"shares":90,"avg_price":91,"value_usd":92,"source":93},"2026-07-01","2026-08-31",198600,563.0360725075528,111818964,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"period_start":95,"period_end":96,"shares":97,"avg_price":98,"value_usd":99,"source":100},"2026-04-01","2026-06-30",582329,570.7149971064467,332343893.55,{"accession":101,"form":58,"as_of":96,"filed_at":102,"url":103},"0000874716-26-000123","2026-08-04","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F874716\u002F000087471626000123\u002F",[],{"company":106,"data_as_of":51,"items":107},{"cik":6,"name":7,"ticker":8,"exchange":9},[108,116,125,133,140],{"period_start":95,"period_end":109,"open_market_shares":110,"total_shares":110,"program_shares":110,"asr_shares":14,"avg_price":111,"value_usd":112,"remaining":113,"remaining_unit":114,"source":115},"2026-04-30",357000,576.7,205881900.00000003,2777370000,"usd",{"accession":101,"form":58,"as_of":96,"filed_at":102,"url":103},{"period_start":117,"period_end":118,"open_market_shares":119,"total_shares":119,"program_shares":120,"asr_shares":14,"avg_price":121,"value_usd":122,"remaining":123,"remaining_unit":114,"source":124},"2026-05-01","2026-05-31",140545,140500,562.67,79080455.14999999,2636870000,{"accession":101,"form":58,"as_of":96,"filed_at":102,"url":103},{"period_start":126,"period_end":96,"open_market_shares":127,"total_shares":127,"program_shares":128,"asr_shares":14,"avg_price":129,"value_usd":130,"remaining":131,"remaining_unit":114,"source":132},"2026-06-01",84784,84300,558.85,47381538.4,2552570000,{"accession":101,"form":58,"as_of":96,"filed_at":102,"url":103},{"period_start":88,"period_end":134,"open_market_shares":135,"total_shares":135,"program_shares":135,"asr_shares":14,"avg_price":136,"value_usd":137,"remaining":138,"remaining_unit":70,"source":139},"2026-07-31",172200,559.54,96352788,2380370,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"period_start":141,"period_end":89,"open_market_shares":142,"total_shares":142,"program_shares":142,"asr_shares":14,"avg_price":143,"value_usd":144,"remaining":83,"remaining_unit":70,"source":145},"2026-08-01",26400,585.84,15466176,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"view":147,"sort":148,"total":149,"generated_at":150,"items":151,"next_cursor":14},"all","newest",3,"2026-11-20T10:02:28.348033Z",[152,158,163],{"id":153,"type":154,"event_date":89,"company":155,"amount_usd":92,"amount_estimated":15,"shares":90,"headline":156,"source":157},"2c6804a1-6b24-5e2d-9180-ed7aa0a3fc62","quarterly_repurchase",{"cik":6,"name":7,"ticker":8,"exchange":9},"Idexx Laboratories Inc repurchased 198,600 shares ($112m) in the quarter to Aug 31, 2026",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"id":159,"type":154,"event_date":96,"company":160,"amount_usd":99,"amount_estimated":15,"shares":97,"headline":161,"source":162},"3a2bde61-6959-506a-bc70-08ec19ceff79",{"cik":6,"name":7,"ticker":8,"exchange":9},"Idexx Laboratories Inc repurchased 582,329 shares ($332m) in the quarter to Jun 30, 2026",{"accession":101,"form":58,"as_of":96,"filed_at":102,"url":103},{"id":164,"type":165,"event_date":77,"company":166,"amount_usd":54,"amount_estimated":18,"shares":72,"headline":167,"source":168},"01d6efbd-723f-53f1-ae20-d64407a76c49","authorization_new",{"cik":6,"name":7,"ticker":8,"exchange":9},"Idexx Laboratories Inc authorizes repurchase of up to 78.0m shares",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"company":170,"items":171,"edgar_url":181},{"cik":6,"name":7,"ticker":8,"exchange":9},[172,178],{"accession":57,"form":58,"filed_at":173,"period_end":51,"url":60,"used_for":174},"2026-11-02T16:29:04Z",[175,176,177],"programs","recent_quarters","remaining_total",{"accession":101,"form":58,"filed_at":179,"period_end":96,"url":103,"used_for":180},"2026-08-04T16:16:29Z",[176],"https:\u002F\u002Fwww.sec.gov\u002Fcgi-bin\u002Fbrowse-edgar?action=getcompany&CIK=0000874716"]